{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:23:36Z","timestamp":1789791816256,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.arcmed.2020.05.018","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T17:08:30Z","timestamp":1591204110000},"page":"548-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Relation of Copeptin with Diabetic and Renal Function Markers Among Patients with Diabetes Mellitus Progressing Towards Diabetic Nephropathy"],"prefix":"10.1016","volume":"51","author":[{"given":"Tooba","family":"Noor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farina","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zareen","family":"Kiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehana","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Tassaduq","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeba","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelash","family":"Nankani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2020.05.018_bib1","first-page":"1792","article-title":"Vasopressin contribute to the renal disorder in Insulin-Depending Diabetes Mellitus (IDDM)","volume":"5","author":"Hameed","year":"2011","journal-title":"Aus J Basic App Sci"},{"key":"10.1016\/j.arcmed.2020.05.018_bib2","series-title":"Diabetes Atlas","first-page":"39","year":"2019"},{"key":"10.1016\/j.arcmed.2020.05.018_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/2045-080X.174943","article-title":"Diabetes Mellitus in Pakistan: A major Public Health Concern","volume":"7","author":"Hussain","year":"2016","journal-title":"Archives Pharm Prac"},{"key":"10.1016\/j.arcmed.2020.05.018_bib4","series-title":"Prevalence of Diabetes and associated Risk Factors. Global Borden of Diabetes. Global Report on Diabetes 2016","first-page":"25","year":"2016"},{"key":"10.1016\/j.arcmed.2020.05.018_bib5","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jdiacomp.2015.07.006","article-title":"Association between Copeptin and declining Glomerular Filtration Rate in people with newly diagnosed Diabetes. The Skaraborg Diabetes Register","volume":"29","author":"Pikkemaat","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.arcmed.2020.05.018_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2020.05.018_bib7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patientswith nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2020.05.018_bib8","first-page":"132","article-title":"Impact of diabetes in renal diseases in Saudi Arabia","volume":"162","author":"AI-Khader","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.arcmed.2020.05.018_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1542\/pir.29.11.374","article-title":"Type 1 diabetes mellitus in pediatrics","volume":"29","author":"Cooke","year":"2008","journal-title":"Pediatr Rev Quiz"},{"key":"10.1016\/j.arcmed.2020.05.018_bib10","first-page":"317","article-title":"Regulation of plasma vasopressin in insulin-dependent diabetes mellitus","volume":"249","author":"Zerbe","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1016\/j.arcmed.2020.05.018_bib11","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V76842","article-title":"Vasopressin Increases Glomerular Filtration Rate in Conscious Rats through Its Antidiuretic Action","volume":"7","author":"Bouby","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.arcmed.2020.05.018_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ki.1995.2","article-title":"Adaptation of the kidney to protein intake and to urine concentrating activity: Similar consequences in health and CRF","volume":"47","author":"Bankir","year":"1995","journal-title":"Kidney Int"},{"key":"10.1016\/j.arcmed.2020.05.018_bib13","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1681\/ASN.V451091","article-title":"Is the process of urinary urea concentration responsible for a high glomerular filtration rate?","volume":"4","author":"Bankir","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.arcmed.2020.05.018_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jjcc.2012.08.020","article-title":"Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population","volume":"61","author":"Matsue","year":"2013","journal-title":"J Cardiol"},{"key":"10.1016\/j.arcmed.2020.05.018_bib15","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1210\/jc.2014-2295","article-title":"Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease","volume":"99","author":"Roussel","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2020.05.018_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/ckj\/sfs008","article-title":"Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges","volume":"5","author":"Geus","year":"2012","journal-title":"Clin Kid J"},{"key":"10.1016\/j.arcmed.2020.05.018_bib17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1152\/ajprenal.00004.2011","article-title":"Urine albumin as a biomarker in acute kidney injury","volume":"300","author":"Bolisetty","year":"2011","journal-title":"Am J Renal Physiol"},{"issue":"Suppl 1","key":"10.1016\/j.arcmed.2020.05.018_bib18","first-page":"37","article-title":"Copeptin: a biomarker of cardiovascular and renal function","volume":"16","author":"Morgenthaler","year":"2010","journal-title":"Congest Heart Fail"},{"key":"10.1016\/j.arcmed.2020.05.018_bib19","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1161\/CIRCULATIONAHA.109.909663","article-title":"Plasma copeptin and the risk of diabetes mellitus","volume":"121","author":"Enhorning","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.arcmed.2020.05.018_bib20","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1042\/bj1360705","article-title":"Stimulation by vasopressin of glycogen breakdown and gluconeogenesis in the perfused rat liver","volume":"136","author":"Hems","year":"1973","journal-title":"Biochem J"},{"key":"10.1016\/j.arcmed.2020.05.018_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1432-1033.1986.tb09827.x","article-title":"Hormonal regulation of the tricarboxylic acid cycle in the isolated perfused rat liver","volume":"159","author":"Patel","year":"1986","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.arcmed.2020.05.018_bib22","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1210\/JC.2015-2362","article-title":"Copeptin, insulin resistance, and risk of incident diabetes in older men","volume":"100","author":"Wannamethee","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2020.05.018_bib23","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1007\/s00125-012-2545-x","article-title":"Sex differences in the association between plasma Copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study","volume":"55","author":"Abbasi","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.arcmed.2020.05.018_bib24","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1152\/jappl.2001.91.4.1893","article-title":"Sex differences in osmotic regulation of AVP and renal sodium handling","volume":"91","author":"Stachenfeld","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.arcmed.2020.05.018_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/CS20080140","article-title":"Gender and renal functions influence plasma levels of Copeptin in healthy individuals","volume":"116","author":"Bhandari","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.arcmed.2020.05.018_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.psyneuen.2005.07.002","article-title":"The effects of sex and hormonal status on the physiological response to acute psychological stress","volume":"31","author":"Kajantie","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.arcmed.2020.05.018_bib27","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.2337\/dc13-0683","article-title":"Plasma Copeptin and renal outcomes in patients with Type 2 Diabetes and albuminuria","volume":"36","author":"Velho","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2020.05.018_bib28","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/s41598-017-02421-9","article-title":"Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients","volume":"7","author":"Al Rubeaan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.arcmed.2020.05.018_bib29","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s00125-013-2922-0","article-title":"Copeptin, a suurogate marker for arginine vasopressin is associated with declining glomerular filtration in patients with diabetes mellitus (ZODIAC-33)","volume":"56","author":"Boertien","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.arcmed.2020.05.018_bib30","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.2337\/dc16-1003","article-title":"Plasma Copeptin, Kidney Outcomes, Ischemic Heart Disease, and All-Cause Mortality in People with Long-standing Type 1 Diabetes","volume":"39","author":"Velho","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.arcmed.2020.05.018_bib31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ijo.2012.88","article-title":"Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malm\u00f6 Diet and Cancer Study cardiovascular cohort","volume":"37","author":"Enhorning","year":"2013","journal-title":"Int J Obes"},{"key":"10.1016\/j.arcmed.2020.05.018_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.arcmed.2018.04.002","article-title":"Copeptin Plasma Levels are Associated with Decline of Renal Function in Patients with Type 2 Diabetes Mellitus","volume":"49","author":"Villela-Torres","year":"2018","journal-title":"Arch Med Res"},{"key":"10.1016\/j.arcmed.2020.05.018_bib33","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1210\/jc.2016-1113","article-title":"Plasma copeptin, AVP gene variants, and incidence of type 2 diabetes in a cohort from the community","volume":"101","author":"Roussel","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2020.05.018_bib34","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1210\/en.2006-1315","article-title":"Alteration of glucose homeostasis in V1a vasopressin receptor-deficient mice","volume":"148","author":"Aoyagi","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.arcmed.2020.05.018_bib35","doi-asserted-by":"crossref","first-page":"172","DOI":"10.11613\/BM.2013.021","article-title":"Copeptin and its potential role in diagnosis and prognosis of various diseases","volume":"23","author":"Dob\u0161a","year":"2013","journal-title":"Biochem Med"},{"key":"10.1016\/j.arcmed.2020.05.018_bib36","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ahj.2014.11.020","article-title":"Copeptin is an independent predictor of diabetic heart disease and death","volume":"169","author":"SofiaEnh\u00f6rning","year":"2015","journal-title":"AHJ"},{"key":"10.1016\/j.arcmed.2020.05.018_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejogrb.2015.03.006","article-title":"Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome","volume":"189","author":"Taskin","year":"2015","journal-title":"Eur J Obs Gynae Repro Bio"},{"key":"10.1016\/j.arcmed.2020.05.018_bib38","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3747\/pdi.2013.00290","article-title":"A pilot study examining the effects of tolvaptan on residual renal function in peritoneal dialysis for diabetics","volume":"35","author":"Hiramatsu","year":"2015","journal-title":"Perit Dial Int"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440920303064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440920303064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:49:44Z","timestamp":1759261784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440920303064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0188440920303064"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2020.05.018","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relation of Copeptin with Diabetic and Renal Function Markers Among Patients with Diabetes Mellitus Progressing Towards Diabetic Nephropathy","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2020.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 IMSS. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}